Intellia Therapeutics, Inc. (NTLA) Insider Ownership

Historic Insider Ownership Trends

NTLA's three largest insider shareholders as of March 23, 2026 are John M Leonard (President And Ceo, 1.17Mn shares), Jose E Rivera (Evp, General Counsel, 162.39K shares), Edward J Iii Dulac (Evp, Chief Financial Officer, 160.96K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
John M Leonard President And Ceo 1,169,739 0 03 Mar, 2026
Jose E Rivera Evp, General Counsel 162,388 0 02 Apr, 2021
Edward J Iii Dulac Evp, Chief Financial Officer 160,963 0 03 Mar, 2026
James Basta Evp, General Counsel 156,794 0 03 Mar, 2026
Birgit C Schultes Evp, Chief Scientific Officer 137,733 0 03 Mar, 2026
William J Chase 134,693 0 22 Aug, 2025
David Lebwohl Evp, Chief Medical Officer 131,192 0 03 Mar, 2026
Eliana Clark Evp, Chief Technical Officer 93,864 0 03 Mar, 2026
Laura Sepp-Lorenzino Evp, Chief Scientific Officer 77,388 0 07 Jan, 2025
Michael P Dube Vp, Chief Accounting Officer 69,527 0 03 Mar, 2026
Glenn Goddard Evp, Chief Financial Officer 69,213 0 05 Mar, 2024
Derek Hicks Evp, Chief Business Officer 59,878 0 07 Jan, 2025
Georgia Keresty 31,883 0 18 Jun, 2025
Muna Bhanji 27,203 0 13 Jun, 2025
Frank Verwiel 25,948 0 13 Jun, 2025
Jesse Goodman 24,359 0 02 Jul, 2025
Brian Goff 23,409 0 13 Jun, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
01 Mar, 2026 Eliana Clark Common Stock A 7,353 $0.00 94,471 D A
01 Mar, 2026 Michael P Dube Common Stock A 17,250 $0.00 69,527 D A
01 Mar, 2026 James Basta Common Stock A 46,080 $0.00 158,005 D A
01 Mar, 2026 David Lebwohl Common Stock A 9,943 $0.00 131,192 D A
01 Mar, 2026 Edward J Iii Dulac Common Stock A 61,280 $0.00 160,963 D A
01 Mar, 2026 John M Leonard Common Stock A 156,400 $0.00 1,169,739 D A
01 Mar, 2026 Birgit C Schultes Common Stock A 39,200 $0.00 137,733 D A
02 Mar, 2026 James Basta Common Stock D 1,211 $13.78 156,794 D S
01 Mar, 2026 Edward J Iii Dulac Stock Option (right to buy) A 87,543 $0.00 87,543 D A
01 Mar, 2026 Birgit C Schultes Stock Option (right to buy) A 56,000 $0.00 56,000 D A
01 Mar, 2026 David Lebwohl Stock Option (right to buy) A 14,204 $0.00 14,204 D A
02 Mar, 2026 Eliana Clark Common Stock D 607 $13.78 93,864 D S
01 Mar, 2026 James Basta Stock Option (right to buy) A 65,829 $0.00 65,829 D A
01 Mar, 2026 Eliana Clark Stock Option (right to buy) A 10,505 $0.00 10,505 D A
01 Mar, 2026 John M Leonard Stock Option (right to buy) A 225,400 $0.00 225,400 D A
05 Jan, 2026 Michael P Dube Common Stock D 2,989 $9.21 52,277 D S
05 Jan, 2026 John M Leonard Common Stock D 34,146 $9.21 1,013,339 D S
05 Jan, 2026 Eliana Clark Common Stock D 9,515 $9.21 87,118 D S
05 Jan, 2026 Birgit C Schultes Common Stock D 8,508 $9.21 98,533 D S
05 Jan, 2026 David Lebwohl Common Stock D 11,903 $9.21 121,249 D S